>> Satraplatin does not produce the same kinds of side effects as cisplatin, carboplatin, and oxaliplatin; hence, the usual platinum “tells” were not even available to the clinicians. <<
I guess we'll see when the briefing documents come out.
Look , I have no reason to think that Satraplatin would be any less effective than other platinum compounds. It's just that others are so comfortable in assuming that's the case without proof . IF there IS a "tell" , then the pain measure is suspect , and you're left with a questionable surrogate endpoint result that's connected to a true clinical benefit by faith , and faith alone.
